It is with immense pride and enthusiasm that we announce OneTech's evolution from a project within Capital Enterprise to a fully independent not-for-profit. This significant milestone, set to occur in the coming weeks, marks an exciting new chapter in OneTech's...

A flurry of headlines erupted after Prime Minister Rishi Sunak announced a new Unicorn Kingdom initiative to create more billion-dollar startups in the UK. Some people didn’t like the name; others questioned the decision, announced in the Autumn Budget, to slash...

Arta Selmani (above right, pictured with her co-founder Dr Livia Ribeiro de Souza) is a two-time founder and the CEO of Mimicrete, a deep tech startup working to create self-healing concrete systems. We chatted at Mimicrete’s base in Cambridge. Capital Enterprise: How...

Nineteen teams from Cancer Tech Accelerator came together at IDEALondon for a pitch day which saw six promising projects selected to move forward to Phase II of the programme. Now in its second year, the consortium, backed by Cancer Research UK, its innovation engine,...

We caught up with Elise Jenkins and Ben Woodington, alums of our Cancer Tech Accelerator and the founders of Opto Biosystems. A bioelectronics startup, Opto aims to revolutionise healthcare with miniaturised sensors that can be implanted into the brain to deliver a...

We caught up with Claudine Adeyemi, founder of Earlybird, a voice-based onboarding tool designed specifically for employability providers and a 2019 alum of our OneTech programme.  The conversation ranged from Claudine’s background as a lawyer to the single most...

There’s been a lot of discussion around university spinouts recently, and not always for the right reasons. Many of the companies we support at Capital Enterprise through our health and life science programmes are spinouts, and even our non-spinouts tend to include...

We sat down with George Neville-Jones, a co-founder of venture builder Cambridge Future Tech and CEO of the recently-launched GitLife Biotech, for a conversation about partnering with universities, creating startups, and why he’s excited about working on the GitHub of...

Chancellor Jeremy Hunt recently told an audience of tech executives that he wants to make Britain “the next Silicon Valley,” with health and life sciences singled out as a priority area. This is an excellent goal, and one we are in some ways already well-positioned to...

Turing Biosystems has developed an interpretable AI that allows the integration of multiple layers of data for clinicians and biopharma companies to optimise treatments and therapies. We sat down with Adam Amara and Rémy Boutonnet, the two co-founders, to talk about...

The news that Radical Ventures is raising a new $550 million fund to invest in AI startups, with a London outpost headed by Aaron Rosenberg formerly of DeepMind, is an excellent sign for the UK's startup ecosystem. London’s AI cluster is genuinely a leader in the...

We recently hosted a Demo Day for the Barclays Eagle Labs Funding Readiness Programme at our IDEALondon base. With more than 300 companies enrolled in the latest autumn 2022 cohort alone, it was tough to whittle down to a handful to showcase. If you’re interested in...